Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

Go back to Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
(NASDAQ: CABA) Delayed: 3.04 +0.03 (1.00%)
Previous Close $3.01    52 Week High
Open $2.93    52 Week Low
Day High $3.12    P/E N/A 
Day Low $2.93    EPS
Volume 653,021       

(NASDAQ: CABA) Delayed: 3.04 +0.03 (1.00%)
Previous Close $3.01    52 Week High
Open $2.93    52 Week Low
Day High $3.12    P/E N/A 
Day Low $2.93    EPS
Volume 653,021